TAHO Pharma (6467) reported revenue of NT$10,000 for Oct 2026, -99.2% from the previous month. Revenue for Jan–Oct 2026 was NT$5.9 million (-24.2% year on year).
In Oct 2026, it ranked No. 154 by revenue among 160 Biotech & Medical companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$10,000 | — | -99.2% |
| Sep 2026 | NT$1.2 million | — | -31.3% |
| Aug 2026 | NT$1.7 million | +2,874.1% | +3.2% |
| Jul 2026 | NT$1.7 million | — | +26.8% |
| Jun 2026 | NT$1.3 million | — | — |
| May 2026 | NT$0 | -100.0% | — |
| Apr 2026 | NT$0 | -100.0% | -100.0% |
| Mar 2026 | NT$10,000 | -99.2% | — |
| Feb 2026 | NT$0 | -100.0% | -100.0% |
| Jan 2026 | NT$23,000 | -90.6% | -82.4% |
| Dec 2025 | NT$131,000 | — | -68.7% |
| Nov 2025 | NT$418,000 | — | — |
| Oct 2025 | NT$0 | — | — |
| Sep 2025 | NT$0 | — | -100.0% |
| Aug 2025 | NT$58,000 | — | — |
| Jul 2025 | NT$0 | — | — |
| Jun 2025 | NT$0 | — | -100.0% |
| May 2025 | NT$1.7 million | — | -44.2% |
| Apr 2025 | NT$3.1 million | — | +151.1% |
| Mar 2025 | NT$1.2 million | — | -20.2% |
| Feb 2025 | NT$1.5 million | — | +527.9% |
| Jan 2025 | NT$244,000 | — | — |
| Dec 2024 | NT$0 | — | — |
| Nov 2024 | NT$0 | — | — |
| Oct 2024 | NT$0 | — | — |
Jan–Oct 2026 cumulative: NT$5.9 million (-24.2% YoY)
Other Biotech & Medical companies
Compare with peers: TAHO Pharma vs PEC / TAHO Pharma vs Lotus Pharm / TAHO Pharma vs Bora
| Company | Revenue | YoY |
|---|---|---|
| PEC | NT$2.84 billion | +102.0% |
| Lotus Pharm | NT$2.13 billion | -22.5% |
| Bora | NT$1.99 billion | +15.9% |
| Great Tree Pharmacy | NT$1.67 billion | +1.5% |
| EXCELSIOR | NT$1.02 billion | +38.6% |
| PEGAVISION | NT$793 million | +13.0% |
| Synmosa Biopharma | NT$766.6 million | +41.2% |
| Y.S.H. | NT$749.4 million | +4.4% |
Company remark (original Chinese)
主要品項仍在研發階段
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16